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Twin and family studies indicate that the timing of primary tooth eruption is highly heritable, with estimates typ-
ically exceeding 80%. To identify variants involved in primary tooth eruption, we performed a population-based
genome-wide association study of ‘age at first tooth’ and ‘number of teeth’ using 5998 and 6609 individuals, re-
spectively, from the Avon Longitudinal Study of Parents and Children (ALSPAC) and 5403 individuals from the
1966 Northern Finland Birth Cohort (NFBC1966). We tested 2 446 724 SNPs imputed in both studies. Analyses
were controlled for the effect of gestational age, sex and age of measurement. Results from the two studies
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were combined using fixed effects inverse variance meta-analysis. We identified a total of 15 independent loci,
with 10 loci reaching genome-wide significance (P < 5 3 1028) for ‘age at first tooth’ and 11 loci for ‘number of
teeth’. Together, theseassociationsexplain6.06%of thevariation in ‘ageoffirst tooth’ and4.76%of thevariation
in ‘number of teeth’. The identified loci included eight previously unidentified loci, some containing genes
known to play a role in tooth and other developmental pathways, including an SNP in the protein-coding
region of BMP4 (rs17563, P 5 9.080 3 10217). Three of these loci, containing the genes HMGA2, AJUBA and
ADK, also showed evidence of association with craniofacial distances, particularly those indexing facial
width. Our results suggest that the genome-wide association approach is a powerful strategy for detecting var-
iants involved in tooth eruption, and potentially craniofacial growth and more generally organ development.
INTRODUCTION
Primary tooth eruption is a complex and highly regulated process
through which primary teeth enter the mouth and become
visible. Prior to eruption, mononuclear cells move to the dental
follicle and fuse to form osteoclasts. These osteoclasts subse-
quently resorb alveolar bone and in doing so form an
eruption pathway through which the primary dentition can
then emerge (1).
Twin studies have provided insight into the genetic control of
primary tooth eruption during childhood. The ‘Dental Develop-
ment and Oral Health of Australian Twins and Their Families’
was a longitudinal study of 98 sets of twins of European ancestry
aged between 1 and 3 years of age that aimed to assess the degree
to which variation in tooth eruption was due to genetic factors.
Although there was no statistically significant difference in erup-
tion times between zygosity and the sexes, there was strong
genetic control with regard to the timing of primary incisor erup-
tion with an estimated heritability of  82 to 94% in males, and
71 to 96% in females (2).
The majority of current knowledge regarding the genetics of
tooth eruption and tooth development has been acquired from
studies involving transgenic mice and other model organisms,
including fish and reptiles, as well as from clinical genetic
studies of humans with congenital disorders in which dental ab-
normalities are a feature. For example, studies in mice have
implicated a host of signalling pathways as being critical in
proper tooth eruption and development, including those involv-
ing the gene families Bmp, Eda, Fgf, Shh and Wnt, among others
(3–5). These pathways are integrated at several stages of the
tooth development process and the network appears to be
highly conserved evolutionarily across species (4). Disruption
of these pathways typically results in severe aberrations of den-
tition, including tooth agenesis or arrest in the early stages of
tooth development (3).
Population-based genome-wide association studies (GWASs)
of tooth eruption in children have the capacity to provide comple-
mentary information to these studies, by identifying common
genetic variation which is associated with non-pathological dif-
ferences in the timing of tooth eruption between individuals.
Loci implicated by GWASs may not necessarily be the same as
those that have been identified in molecular studies or be asso-
ciated with abnormalities, but rather may reflect variation in
genes important in more subtle aspects of tooth development, in-
cluding differences in the timing of tooth eruption or perhaps even
genetic variation important in more generalized aspects of growth
and development.
In a previous genome-wide meta-analysis of primary tooth
eruption, we identified five loci associated with ‘age at first
tooth’ and ‘number of teeth’ at 1 year of age at genome-wide
levels of significance, and a further five at suggestive levels of
significance (6). Many of these loci contained genes previously
implicated in tooth or other organ development. A more recent
GWAS of secondary tooth eruption identified two of the same
loci as well as two others containing the genes ADK and
CACNA1S/TMEM9 (7). What was particularly striking about
both studies was the number of loci displaying large effect
sizes. Typically, GWASs of quantitative traits require tens of
thousands of individuals to identify common variants of small
effect. However, the tooth eruption phenotype appears to be
influenced by some loci of comparably large effect (i.e. .1%
of the phenotypic variance), implying that the genome-wide
study of primary tooth eruption might be a powerful strategy
not only at detecting variants involved in dentition, but also
SNPs that may exert pleiotropic actions on other aspects of
growth and development.
In order to identify novel variants involved in primary tooth
eruption, we doubled the size of our previous population-based
genome-wide association meta-analysis, increasing our sample
to include 5998 and 6609 individuals from the Avon Longitudinal
Study of Parents and Children (ALSPAC) for ‘age at first tooth’
and ‘number of teeth’, and a further 5403 individuals from the
1966 Northern Finland Birth Cohort (NFBC1966). SNPs that
met the criteria for genome-wide significance (P, 5 × 1028)
were then assessed for association with other related phenotypes,
including measures of craniofacial shape and size, secondary
tooth eruption, and height. The aim of our study was to (i)
identify novel genetic loci associated with tooth eruption, and
(ii) to investigate whether variants associated with tooth develop-
ment exhibited pleiotropic effects on growth in general. Specific-
ally, we examined the relationship between tooth-associated loci
and eruption of secondary teeth, height, craniofacial size and
shape, as well as possible relationships between known height-
associated loci and tooth eruption.
RESULTS
A total of 2 446 724 SNPs common to both studies were tested
for association with ‘age at first tooth’ and ‘number of teeth at
one year’. All analyses were adjusted for gestational age, sex
and age, where appropriate (see Materials and Methods).
Results from the two studies were combined using fixed
effects inverse variance meta-analysis, where effect size
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estimates are weighted according to the inverse of their standard
errors. Q–Q plots indicated little inflation of the test statistics in
the individual cohorts and for the meta-analysis overall (‘Age at
first tooth’ LAMBDA ALSPAC ¼ 1.04; ‘Age at first tooth’LAMBDA
NFBC1966 ¼ 1.05; LAMBDA META ¼ 1.07; ‘Number of teeth’:
LAMBDA ALSPAC ¼ 1.02; LAMBDA NFBC1966 ¼ 1.04; LAMBDA
META ¼ 1.06) (Supplementary Material, Fig. S1). The genomic
inflation factor l is well known to increase with sample size;
we, therefore, also calculated l1000 values (8) for the ‘Age at
first tooth’ (l1000 ¼ 1.01) and ‘Number of teeth’ (l1000 ¼
1.00) meta-analyses. Both values are consistent with little
latent population stratification or other systematic biases affect-
ing our results.
We identified 10 loci reaching genome-wide significance (P,
5 × 1028) for ‘age at first tooth’ and a further 11 loci for ‘number
of teeth’, giving a total of 15 independent loci (Fig. 1). The full
GWAS results corresponding to Figure 1 are available from the
Human Molecular Genetics website. Table 1 shows the
top-ranking SNPs for each phenotype at each locus. Eight of
these loci are novel associations; the top SNPs at these loci are
rs17563 (BMP4), rs10740993 (CACNB2), rs4937076 (CDON),
rs1799922 (CALU/OPN1SW), rs997154 (AJUBA/C14orf93),
rs7924176 (ADK), rs412000 (TEX14/RAD51C) and rs9316505
(DLEU7). Four of the loci identified confirm previously reported
genes/regions (6) (KCNJ2, MSRB3, IGF2BP1 and EDA). Further-
more, we detected genome-wide significance for the variant
rs17101923 in the HMGA2 region (‘number of teeth’ P ¼ 1.1 ×
10210, Table 1), rs10932688 in the 2q35 region and the
rs6568401 variant in the 6q21 region, which were identified at
suggestive levels of significance in a previous study (6). We
also note that SNPs at the RAD51L1 locus reported as genome-
wide significant for association with ‘number of teeth’ in Pillas
et al. (6) did not meet the 5 × 1028 threshold in this study, al-
though there was still suggestive evidence for association at this
locus [‘Age at first tooth’ (rs17105278): P ¼ 2.1 × 1026;
‘Number of teeth’(rs1956529): P ¼ 6.4× 1027].
Each SNP that reached genome-wide significance explained
only a small fraction of the overall phenotypic variation in
‘age at first tooth’ (0.05–1.14%, ALSPAC; 0.06–1.45%,
NFBC1966) and ‘number of teeth’ (0.09–0.94%, ALSPAC;
0.03–0.92%, NFBC1966). Pooling together the effects of the
top SNPs at the genome-wide significant loci (Table 1) into a
single allelic score explained 6.06% of the overall phenotypic
variation in ‘age at first tooth’ and 4.76% of the variation in
‘number of teeth’. We also report loci displaying suggestive
levels of association (Supplementary Material, Tables S1 and
S2), 5 × 1026. P . 5 × 1028, which included SNPs in the
TMEM9 region that were reported as genome-wide significant
in the study of secondary dentition by Geller et al. (7).
Supplementary Material, Figures S2 and S3 show LocusZoom
plots of regression analyses for ‘age at first tooth’ and ‘number of
teeth’, respectively, at each genome-wide significant locus after
meta-analysis (9). For most loci, there appeared to be evidence
of secondary signals independent of the lead SNP at the locus.
To quantify the evidence for independent secondary signals, we
first calculated the effective number of statistical tests in each
region using Nyholt’s procedure (10). For each locus, we esti-
mated the threshold for a family-wise error rate of 5% by
dividing alpha ¼ 0.05 by the corresponding number of effective
tests in that region, and used this threshold for declaring a
secondary signal as significant. These thresholds as well as the
strongest P-value in each region after conditioning on the lead
SNP are presented in Supplementary Material, Table S3. These
analyses showed that there were likely to be independent second-
ary signals at rs11077486 (KCNJ2 KCNJ160), rs2520397
(FAM155E–EDA), rs1951867 (BMP4), rs1472259 (HMGA2)
and rs8069452 (IGF2BP1) for ‘age at first tooth’ and rs9788982
(KCNJ2 KCNJ160), rs2804391 (FAM155E–EDA), rs1458991
(BMP4), rs9894411 (IGF2BP1), rs1976274 (MSRB3) and
rs1472259 (HMGA2) for ‘number of teeth’ (Supplementary Ma-
terial, Table S3).
We next investigated whether the SNPs at our top loci have
pleiotropic effects, specifically whether they are associated with
both primary tooth and craniofacial development. A recent
GWAS investigated the genetic determinants of 54 measures of
craniofacial shape and size recorded in ALSPAC (Supplementary
Material, Fig. S4) (11). We used these data to test for association
betweenthe topSNPsatgenome-widesignificanceandeachof the
54 measures of craniofacial development. Because of the large
number of correlated craniofacial phenotypes analysed, and
consequently the large number of statistical tests performed, we
calculated empirical P-values for each SNP permuting each
Figure 1. Manhattan plots for meta-analysis of ‘age at first tooth’ and ‘number of teeth’, respectively
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Table 1. Fifteen loci identified at genome-wide significance in meta-analysis of ‘age at first tooth’ or ‘number of teeth’ in ALSPAC and NFBC1966
Marker Gene region/locus Chromosome Base position A1/A2 Effect
ALSPAC
SE
ALSPAC
% Var
ALSPAC
P-value
ALSPAC
Effect
NFBC
SE
NFBC
% Var
NFBC
P-value
NFBC
Effect
meta
SE
meta
P-value meta
Age at first tooth
rs10932688 2q35 2 217 571 726 G/C 20.107 0.048 0.05 2.7 × 1022 20.106 0.037 0.13 4.0 × 1023 20.106 0.029 2.9 × 1024
rs6568401 6q21 6 106 295 511 C/T 20.228 0.049 0.33 3.1 × 1026 20.168 0.037 0.37 7.1 × 1026 20.190 0.030 1.5 × 10210
rs1799922 CALU/OPN1SW 7 128 202 431 T/G 20.148 0.044 0.16 7.8 × 1024 20.135 0.037 0.23 3.2 × 1024 20.140 0.029 8.8 × 1027
rs10740993 CACNB2 10 18 482 488 C/T 20.175 0.043 0.24 4.7 × 1025 20.118 0.035 0.19 6.7 × 1024 20.141 0.0271 1.9 × 1027
rs7924176 ADK VCL AP3M1 10 75 965 795 A/G 20.261 0.043 0.58 1.2 × 1029 20.081 0.037 0.06 2.5 × 1022 20.167 0.028 1.8 × 1028
rs4937076 CDON 11 125 331 912 A/G 20.186 0.043 0.27 1.8 × 1025 20.127 0.035 0.21 3.3 × 1024 20.150 0.027 4.0 × 1028
rs12229918 MSRB3 12 64 048 325 C/G 20.273 0.044 0.60 7.3 × 10210 20.176 0.039 0.37 5.3 × 1026 20.218 0.029 7.3 × 10214
rs17101923 HMGA2 12 64 624 469 G/T 20.282 0.053 0.44 9.99 × 1028 20.170 0.041 0.30 3.5 × 1025 20.212 0.033 6.3 × 10211
rs9316505 DLEU7 13 50 288 599 A/G 20.122 0.043 0.10 4.8 × 1023 20.095 0.038 0.08 1.2 × 1022 20.107 0.028 1.8 × 1024
rs997154 AJUBA/C14orf93 14 22 534 322 G/A 20.132 0.051 0.08 1.0 × 1022 20.142 0.038 0.23 2.2 × 1024 0.138 0.031 6.9 × 1026
rs17563 BMP4 14 53 487 272 G/A 20.339 0.043 0.98 4.9 × 10215 20.160 0.038 0.29 2.9 × 1025 20.239 0.029 9.1 × 10217
rs1994969 IGF2BP1 17 44 435 430 T/G 20.211 0.043 0.36 1.0 × 1026 20.203 0.035 0.61 4.5 × 1029 20.206 0.027 2.3 × 10214
rs412000 TEX14/RAD51C 17 54 064 057 C/G 20.752 0.0431 0.24 5.0 × 1025 20.157 0.035 0.34 8.2 × 1026 20.1641 0.027 1.7 × 1029
rs8080944 KCNJ2 KCNJ16 17 65 697 181 A/G 20.378 0.045 1.14 2.8 × 10217 20.317 0.036 1.45 2.0 × 10218 20.341 0.028 7.6 × 10234
rs11796357 FAM155E - EDA X 68 581 724 G/A 20.290 0.041 0.81 1.1 × 10212 20.222 0.033 0.85 2.0 × 10211 20.250 0.026 3.1 × 10222
Number of teeth
rs10932688 2q35 2 217 571 726 G/C 0.118 0.035 0.09 6.4 × 1024 0.173 0.038 0.39 5.8 × 1026 0.143 0.026 2.5 × 1028
rs6568401 6q21 6 106 295 511 C/T 0.156 0.035 0.25 8.4 × 1026 0.058 0.039 0.03 1.4 × 1021 0.112 0.026 1.6 × 1025
rs1799922 CALU/OPN1SW 7 128 202 431 T/G 0.138 0.031 0.28 1.0 × 1025 0.152 0.039 0.25 9.6 × 1025 0.144 0.024 4.0 × 1029
rs10740993 CACNB2 10 18 482 488 C/T 0.132 0.031 0.26 1.7 × 1025 0.153 0.036 0.3 2.2 × 1025 0.141 0.023 1.7 × 1029
rs7924176 ADK VCL AP3M1 10 75 965 795 A/G 0.248 0.031 0.94 8.8 × 10216 0.109 0.038 0.19 3.9 × 1023 0.193 0.024 7.8 × 10216
rs4937076 CDON 11 125 331 912 A/G 0.082 0.031 0.11 7.5 × 1023 0.121 0.037 0.19 9.9 × 1024 0.098 0.024 3.1 × 1025
rs12229918 MSRB3 12 64 048 325 C/G 0.144 0.032 0.30 5.3 × 1026 0.158 0.041 0.21 1.1 × 1024 0.149 0.025 2.3 × 1029
rs17101923 HMGA2 12 64 624 469 G/T 0.191 0.037 0.36 3.3 × 1027 0.169 0.043 0.29 7.3 × 1025 0.182 0.028 1.1 × 10210
rs9316505 DLEU7 13 50 288 599 A/G 0.132 0.031 0.24 1.5 × 1025 0.133 0.039 0.17 6.2 × 1024 0.133 0.024 3.4 × 1028
rs997154 AJUBA/C14orf93 14 22 534 322 G/A 0.124 0.037 0.10 7.0 × 1024 0.181 0.040 0.35 5.8 × 1026 0.150 0.027 2.6 × 1028
rs17563 BMP4 14 53 487 272 G/A 0.117 0.031 0.16 1.7 × 1024 0.039 0.040 0.03 3.3 × 1021 0.087 0.025 3.6 × 1024
rs1994969 IGF2BP1 17 44 435 430 T/G 0.189 0.031 0.50 8.5 × 10210 0.190 0.036 0.54 1.6 × 1027 0.190 0.024 7.2 × 10216
rs412000 TEX14/RAD51C 17 54 064 057 C/G 0.105 0.031 0.12 7 × 1024 0.098 0.037 0.10 7.4 × 1023 0.102 0.024 1.6 × 1025
rs8080944 KCNJ2 KCNJ16 17 65 697 181 A/G 0.192 0.032 0.54 1.6 × 1029 0.317 0.036 0.92 1.9 × 10218 0.221 0.024 1.5 × 10219
rs11796357 FAM155E - EDA X 68 581 724 G/A 0.175 0.029 0.56 2.5 × 1029 0.231 0.035 0.74 2.2 × 10211 0.199 0.022 6.9 × 10219
SNPs showing a genome-wide significance of P, 5 × 1028 in the meta-analysis. The P-value for each cohort is corrected for gestational age and sex. ALSPAC was also corrected for age at measurement.
P-values from the meta-analysis were calculated using a fixed effects inverse variance model. All alleles refer to the forward strand. Positions of SNPs reported correspond to HapMap release II build 36. The effect
allele A1 (bold) is defined as the allele associated with faster tooth eruption and an increase in the number of teeth.
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genotype against the 54 phenotypes.This procedure is less conser-
vative than a Bonferroni correction (which assumes that the phe-
notypes are independent) and ensures that the correlation between
phenotypes is properly accounted for in the multiple testing cor-
rection. Empirical P-values were calculated for each SNP and
those with P, 0.05 were declared significant (Table 2). Using
this procedure, we identified three SNPs, which were associated
with 10 of the 54 craniofacial measures. Specifically, the SNP
rs17101923 (HMGA2) was associated with measurements index-
ing the width of the upper region of the face and nose (Table 2 and
Supplementary Material, Fig. S4). Alleles that were associated
with increased face width were associated with increased
number of teeth and earlier tooth eruption. The rs7924176
marker (ADK) was also associated with measures indexing the
width of the nose. Alleles that predisposed to earlier tooth eruption
were also associated with a wider nose. Furthermore, rs997154
(AJUBA) was associated with an increase in height and promin-
ence of the mid-brow.
We also looked up the top SNP from each of the 15 genome-
wide significant loci in a previous analysis of secondary
dentition and found that 7 were at least nominally associated
(P , 0.05) with the number of permanent teeth between 6 and
14 years old (Supplementary Material, Table S4) (7). For the
three loci (i.e. HMGA2, BMP4, MSRB3) associated with ‘age
at first tooth’ at genome-wide significance, the allele associated
with earlier primary tooth eruption was also associated with a
greater number of permanent teeth. Furthermore at the four
loci (ADK/VCL/AP3M1, 2q35, CACNB2, 6q21) associated
with ‘number of primary teeth’, the allele associated with a
greater number of teeth at 1 year was also the allele associated
with greater number of permanent teeth (6–14 years).
In order to explore the connection between known height-
associated SNPs and teeth phenotypes more deeply, we took
180 robustly associated height variants from the Lango Allen
et al. (12) Giant Consortium meta-analysis and examined the
degree to which these SNPs were associated with tooth eruption
(Supplementary Material, Table S5). Several height-associated
SNPs showed strong evidence of association with tooth eruption
in the expected direction (i.e. the height increaser allele was asso-
ciated with faster tooth eruption/more teeth), including
rs1351394 in HMGA2 (‘Age at first tooth’: P ¼ 5.3 × 1027;
‘Number of teeth’: P ¼ 1.0 × 1029), rs12534093 in IGF2BP3
(‘Age at first tooth’: P ¼ 0.0026; ‘Number of teeth’: P ¼ 2.7
× 1025), rs1490384 near C6orf173 (‘Age at first tooth’: P ¼
1.0 × 1027; ‘Number of teeth’: P ¼ 0.12) and rs1570106 in
RAD51L1 (‘Age at first tooth’: P ¼ 0.00012; ‘Number of
teeth’: 2.3 × 1026). Overall, however, the number of height-
associated SNPs for which the height increaser allele had a posi-
tive effect on faster tooth eruption was not greater than expected
by chance (‘Age at first tooth’: 89/180 SNPs in the expected dir-
ection P ¼ 0.94; ‘Number of teeth’: 92/180 SNPs in the expected
direction P ¼ 0.71). Likewise, a weighted allelic score of height-
associated SNPs did not significantly predict the age at first tooth
or the number of teeth (‘Age at first tooth’: PMETA ¼ 0.18;
‘Number of teeth’: PMETA ¼ 0.44).
We alsoregressedheightat17 years inALSPACand at 31 years
in NFBC1966 on an allelic score constructed from the genome-
wide significant SNPs for ‘Age at first tooth’ and ‘Number of
teeth’ listed in Table 1. Allelic scores for ‘Age at first tooth’
(PMETA ¼ 0.0012) and ‘Number of teeth’ (PMETA¼ 9.8×
1024) showed moderate evidence of association with height;
however, the associations appeared to be driven largely by var-
iants in HMGA2 and BMP4. After these SNPS were removed
from the construction of the scores, the evidence for association
attenuated markedly (‘Age at first tooth’ PMETA ¼ 0.11;
‘Number of teeth’ PMETA¼ 0.04).
Finally, we conducted a pathway analysis using the ALLIGA-
TOR software (13). In the pathway analyses, an SNP association
P-value threshold of 0.005 gave the most significant over-
representation of genes in pathways in the ‘age at first tooth’
GWAS (see Materials and Methods and Supplementary Material,
Table S6a). The top 20 pathways (of the 2276 considered) from
this analysis are shown in Table 3; 11 of these pathways had
pathway association P-values,0.001 and the P-value associated
with this degree of overrepresentation is 0.004 (Supplementary
Material, Table S6A). However, none of the association P-value
Table 2. Association results for SNPs that met P, 0.05 after permutation in the analysis of craniofacial size and shape
Traita Marker Gene/locus Alleles Frequency
of A1
RSQR Effect SE P-value Permuted
P-value
Width of eye region
psL-psR: left-to-right palpebrale superius distance rs17101923 HMGA2 G/T 0.78 0.9645 0.11 0.028 0.00011 0.0042
piL-piR: left-to-right palpebrale inferius distance rs17101923 HMGA2 G/T 0.78 0.9645 0.109 0.028 0.00012 0.0049
exR.yz: distance of the right exocanthion from the YZ plane rs17101923 HMGA2 G/T 0.78 0.9645 0.099 0.028 0.00043 0.018
enL.yz: distance of the left endocanthion from the YZ plane rs17101923 HMGA2 G/T 0.78 0.9645 0.096 0.028 0.00067 0.025
enL-enR: left-to-right endocanthion distance rs17101923 HMGA2 G/T 0.78 0.9645 0.094 0.028 0.00074 0.028
exL-exR: left-to-right exocanthion distance rs17101923 HMGA2 G/T 0.78 0.9645 0.093 0.028 0.00087 0.033
Width of lower part of nose
prn-alL: pronasale to left alare distance rs17101923 HMGA2 G/T 0.78 0.9645 0.08 0.025 0.0013 0.044
sn-alL: subnasale to left alare rs7924176 ADK VCL AP3M1 A/G 0.58 0.9714 0.071 0.022 0.0013 0.049
alL-alR: left-to-right alare distance rs17101923 HMGA2 G/T 0.78 0.9645 0.078 0.024 0.0014 0.048
Height and prominence of the mid-brow
g-men: glabella to mid-endocanthion distance rs997154 AJUBA G/A 0.23 0.9698 0.104 0.027 0.00016 0.0069
All alleles are on the forward strand. The effect allele is displayed in bold font and in each case is also the allele associated with increased the number of teeth at 12
months. Freq1 is the allele frequency of the effect allele.
aSee Supplementary Material Figure S4 for additional information on landmark positions.
Human Molecular Genetics, 2013, Vol. 22, No. 18 3811
thresholds applied to the ‘number of teeth’ GWAS resulted in a
significant over-representation of pathways (Supplementary Ma-
terial, Table S6B). In Discussion, we focus on the results from the
‘age at first tooth’ GWAS.
DISCUSSION
We report genetic variants at 15 loci associated with primary
tooth eruption at genome-wide significant levels, including 8
novel variants within or near the following genes: BMP4,
CACNB2, CDON, CALU/OPN1SW, AJUBA, DLEU7, TEX14/
RAD51C and ADK. We confirm association with six loci previ-
ously associated with primary tooth eruption (KCNJ2/KCNJ16,
EDA, IGF2BP1, MSRB3, Chr6q21, 2q35) (6). The SNPs from
the ADK and 2q35 associations have also been previously asso-
ciated with secondary tooth eruption (7).
Two genes identified in this study that have been implicated re-
peatedly in animal and human models of tooth development are
BMP4 and EDA. BMP4 is a member of the transforming growth
factor beta-1 superfamily of secretory signalling molecules that
play essential roles in embryonic development, including meso-
derm induction, tooth development, limb formation, bone induc-
tion and fracture repair (14). Mutations in BMP4 can cause eye,
brain and digit developmental anomalies (14). BMP4 is expressed
early in tooth development and has an expression profile which
coincides with the shift of odontogenic potential from the epithe-
lium to the mesenchyme during development of the tooth bud
(15). Recent data suggest that BMP4 signalling suppresses tooth
developmental inhibitors in the tooth mesenchyme, including
Dkk2 and Osr2, and synergizes with Msx1 to activate mesenchy-
malodontogenicpotential for toothmorphogenesisandsequential
tooth formation (16). Given BMP4’s important role in tooth
development, it is perhaps not surprising that SNPs at this locus
also associatewith timing of tooth eruption. Interestingly, variants
within BMP4 have previously been associated with Parkinson’s
disease (17) and colorectal cancer in other GWASs (18) suggest-
ing pleiotropic actions of this gene.
EDA is a member of the tumour necrosis factor family that
signals through a receptor expressed locally in the placodes of
all ectodermal appendages as well as in primary and secondary
enamel knots (4,19). In humans, mutations in the gene encoding
EDA can cause hypohidrotic ectodermal dysplasia-1 (20).
This syndrome is characterized by a variety of ectodermal abnor-
malities, including missing teeth and defects in tooth morph-
ology in that crowns of the remaining teeth lack cusps and are
conical in shape (20). The ‘Tabby’ mouse (i.e. EDA null
mutant mouse) represents the murine equivalent of hypohidrotic
ectodermal dysplasia-1 (21). These mice often lack incisors and
third molars and typically express simplified tooth morphology,
including missing or fused cusps (22). Conversely, mice that
overexpress EDA in the epithelium develop an extra tooth in
front of the molars (23). The EDA locus was implicated in our
previous GWA study of tooth eruption in humans (6). Our
results confirm that SNPs at this locus are also associated with
subtle effects on tooth development, including alterations in
the timing of tooth eruption.
CACNB2 (rs10740993) is a member of the voltage-gated
calcium channel superfamily, and the third ion channel gene to
be implicated in tooth eruption (24). Mutations in CACNB2
Table 3. Pathway analysis
Pathway Number of significant
genes in pathway
Total number of
genes in pathway
Expected number of
genes on list
P-value Study-wide
P-value
E hits/
study
Signalling events mediated by focal adhesion
kinase
70 567 47.11 ,1024 0.088 0.13
Trail signalling pathway 71 591 47.01 ,1024 0.088 0.13
p53 pathway 22 160 9.24 ,1024 0.088 0.13
Signalling events mediated by the hedgehog
family
13 51 4.78 ,1024 0.088 0.13
Class I PI3K signalling events 66 544 43.87 1024 0.1285 0.19
Syndecan-1-mediated signalling events 72 597 49.57 2.0 × 1024 0.17 0.26
Glypican pathway 92 808 68.2 4.0 × 1024 0.2465 0.42
Hedgehog signalling pathway (KEGG) 11 54 3.68 5.0 × 1024 0.2795 0.51
Signalling events mediated by hepatocyte
growth factor receptor (c-Met)
71 585 49.13 6.0 × 1024 0.3135 0.59
Class I PI3K signalling events mediated by AKT 54 457 35.99 7.0 × 1024 0.3485 0.66
Glypican 1 network 79 685 57.33 8.0 × 1024 0.3845 0.76
Endothelins 49 364 33.3 0.0011 0.4665 1.03
EGF receptor (ErbB1) signalling pathway 79 697 59.01 0.0019 0.6565 1.8
Internalization of ErbB1 79 697 59.01 0.0019 0.6565 1.8
ErbB1 downstream signalling 79 697 59.01 0.0019 0.6565 1.8
Integrins in angiogenesis 13 63 5.7 0.002 0.671 1.89
Prostate cancer (KEGG) 14 79 6.4 0.002 0.671 1.89
Downstream signalling in naı¨ve CD8+ T cells 9 42 3.87 0.0027 0.758 2.54
1 and 2 methylninaphthalene degradation
(KEGG)
3 7 0.31 0.0027 0.758 2.54
Immunoregulatory interactions between A
lymphoid and a non-lymphoid cell
6 34 1.59 0.003 0.7875 2.81
Results of top 20 pathways from the ALIGATOR analyses of the ‘age at first tooth’ GWAS. P-value threshold of 0.005. There were 1358 genes significant at this
threshold from a total of 19 887 genes included in our analysis. All pathways presented are from the NCI pathway interaction database unless stated.
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have been implicated in a form of Brugada syndrome, a genetic
disease characterized by electrocardiogram abnormalities (25).
Variants in the gene have also been associated with hypertension,
systolic and diastolic blood pressure in GWASs (26). Interesting-
ly, the top SNP from the present study is in LD (r2. 0.7) with an
SNP associated with blood pressure from the Ehret et al. study; the
allele associated with earlier tooth eruption is on the same haplo-
type as the allele associated with lower blood pressure.
Variants in DLEU7 have also been associated with height in
three GWASs (27–29), although the LD between the topmost
SNPs from these studies and the topmost SNP from the present
study is low (r2, 0.01), suggesting that the underlying signals
are independent of each other. Transcription factors of DLEU7
are known to have roles in cell proliferation and differentiation
(30).
CDON (rs4937076) is involved in muscle cell differentiation
and cell adhesion. This gene is part of a cell-surface receptor
complex that mediates cell–cell interactions (31). Cell adhesion
molecules have been implicated in several processes, including
cell migration, growth control and tumour genesis. Cole and
Krauss (32) generated mice lacking CDON, 60% of which
failed to survive beyond weaning at postpartum day 21.
CDON2/2 mice displayed the hallmark facial defects asso-
ciated with microforms of holoprosencephaly, including lack
of or solitary central maxillary incisors.
CALU (rs1799922) is a calcium-binding protein found in the
endoplasmic reticulum. It is involved in protein folding and
sorting (33). The gene has no known functions related to tooth
eruption, and variants within this gene have not been associated
with other phenotypes in GWASs.
AJUBA belongs to a group of cell adhesion complexes. It is
involved in cell fate determination (34) and is an important
regulator of the WNT signalling pathway (35). As well as being
associated with the number of teeth at 12 months/15 months, the
variant rs997154 was also associated with G-men distance (i.e.
distance from the glabella to the mid-endocanthion point), sug-
gesting that this gene might be pleiotropically involved in other
aspects of craniofacial development besides dentition.
SNPs at three loci (HMGA2, ADK and AJUBA) showed evi-
dence of association with craniofacial distances, particularly
those indexing facial width. The SNP rs17101923 is located in
an intron of the gene HMGA2 which is known to contain
genetic variants associated with height (29), head circumference
(36), intracranial volume (37) and permanent dentition (7). The
top variant from our study (rs17101923) is in moderate to high
LD with these genetic variants, which could reflect the pleiotrop-
ic action on growth, in general, of a single causal variant. Ligon
et al. (38) report the case of an 8-year-old boy with a de novo peri-
centric inversion of chromosome 12 that truncated the HMGA2
gene. The patient exhibited multiple clinical features, including
premature dentition, enlarged and supernumerary teeth, as well
as macrocephaly, flat supraorbital ridges, widely spaced eyes
and prominent alveolar ridges. Our results suggest that
common SNPs at this locus can also contribute to normal vari-
ation in the timing of tooth eruption and craniofacial distances.
We examined the degree to which known height SNPs were
associated with tooth eruption, and similarly whether SNPs asso-
ciated with tooth eruption explained variance in height. Our ana-
lyses suggest there exists a subset of known height-associated
variants, including those in the HMGA2, IGF2BP3, C6orf173
and RAD51L1 loci that are also associated with tooth eruption.
This may be due to these variants exerting a generalized pleiotrop-
ic effect on many aspects of growth. For example, SNPs in
HMGA2 have been previously associated with other growth-
related phenotypes, including head circumference (36),
intracranial volume (37) and birth weight (39) as well as height
(12). Likewise, SNPs at the C6orf173 locus have been associated
with age at menarche (40). Despite robust associations of a few,
the majority of height-related SNPs were not strongly related to
tooth eruption. A weighted allelic score of height-associated var-
iants was not strongly related to tooth eruptionand there seemed to
be little consistency in the direction of allelic effects for 180
height-associated SNPs across height and tooth eruption pheno-
types. Likewise, the majority of genome-wide significant tooth
eruption SNPs did not appear to be strongly related to height.
The exceptions were SNPs in HMGA2 and BMP4, both which
appear to have pleiotropic actions that have been discussed previ-
ously. Our results suggest that BMP4 is likely to contain novel
height-associated variants and could also be followed up in this
context.
The RAD51 family of genes encode a strand-transfer protein
which is thought to be involved in recombinational repair of
DNA damage and in meiotic recombination; variants in two of
these genes have been highlighted in this study. A variant near
RAD51C was genome-wide significant for tooth eruption; this
gene has been implicated in a Fanconi anaemia-like disorder
(41) as well as in rare monogenic forms of breast and ovarian
cancer (42), but not in tooth development. Further, a variant in
RAD51L1 reported in Lango Allen et al. (12) as being associated
with height also showed suggestive evidence of association with
primary tooth eruption in this study.
The top 20 pathways identified from the pathway analysis are
mostly related to growth and/or cancer. The three genes (BMP4,
CDON, IGF2BP1) associated with ‘age at first tooth’ in the
GWAS meta-analysis are part of the hedgehog-signalling
pathway (P ¼ 5 × 1024), signalling events mediated by the
Hedgehog family (P, 1024) and glypican pathway (P ¼ 4 ×
1024). Hedgehog signalling has been well described in tooth de-
velopment (43), along with heparan sulphate proteoglycans (44).
Growth factors also play a major role in the interaction between
dental epithelium and mesenchyme, as well as cell–cell interac-
tions within these tissues during tooth development (45). Several
growth factor receptor signalling pathways for the epidermal
growth factor receptor and the hepatocyte growth factor receptor
were significant in our analysis [signalling events mediated by
the hepatocyte growth factor receptor (c-Met) P , 6 × 1024,
EGF receptor (ErbB1) signalling pathway, internalization of
ErbB1, ErbB1 downstream signalling, P, 0.0019], which is
of interest as their ligands HGF and EGF have been shown to
play a role in root development in mice (46,47).
Of the four loci associated with primary tooth development in
Pillas et al. (6) and confirmed in this study, three have known de-
velopmental functions: KCNJ2, EDA and IGF2BP1. The link
between normal development and cancer has been noted previ-
ously (48), with both involving shifts between cell proliferation
and differentiation. Five of the 15 loci identified by our study
have been implicated in cancer. As noted earlier, rare mutations
in RAD51C have been implicated in breast and ovarian cancer.
Likewise, a variant in BMP4 has been found to be associated
with colorectal cancer; also a variant in 2q35 has been found to
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be associated with breast cancer. In both cases, the reported SNP
is in high LD with the lead SNP at the respective locus in our
study and was also associated with primary tooth eruption.
However, whereas the allele associated with increased risk of
colorectal cancer was associated with earlier time to tooth erup-
tion, the allele associated with increased risk of breast cancer was
associated with fewer teeth at 12 months. Expression of HMGA2
has been implicated in bladder and lung cancers (49,50). Expres-
sion of IGF II mRNA-binding protein produced by IGF2BP1 has
been implicated in ovarian cancer (51). Furthermore, the
pathway analysis implicated many pathways associated with
cancer.
In summary, we have identified eight new loci affecting
primary tooth eruption, which together with previously identi-
fied loci explain 6.06% of the variation in ‘age of first tooth’
and 4.76% of the variation in ‘number of teeth’. These estimates
compare favourably with larger studies on human height; for
example, using a total sample size of 39 509, Gudbjartsson
et al. discovered 27 loci associated with human height, which to-
gether explained 3.7% of the variation in human height (27).
Several of these variants also appear to exhibit pleiotropic
actions, including effects on craniofacial development, height
and potentially on disease development in later life. Further-
more, we report a number of genes belonging to pathways
involved in growth/development and cancer. A thorough under-
standing of how the functional variants underlying these associa-
tions mediate their effects is likely to yield rich rewards not only
in terms of understanding tooth eruption and craniofacial devel-
opment, but also potentially about how disease develops across
the life course.
MATERIALS AND METHODS
Participants and phenotypes
Genome-wide association analyses of primary tooth eruption
variables were based on data collected from two prospective
birth cohorts: ALSPAC and NFBC1966.
ALSPAC
ALSPAC is a population-based birth cohort study consisting of
14 541 women and their children recruited in the county of
Avon, UK, in the early 1990s (52). Both mothers and children
have been extensively followed from the eighth gestational
week onwards using a combination of self-reported question-
naires, medical records and physical examinations. Biological
samples including DNA have been collected from the partici-
pants. Ethical approval was obtained from the ALSPAC Law
and Ethics Committee and relevant local ethics committees, and
written informed consent provided by all parents. Tooth eruption
phenotypes of thechildrenwerederived fromquestionnairescom-
pleted by the mothers and included items regarding the ‘age at first
tooth’ (assessed at 15months) and the ‘number of teeth’ in the
child’s mouth (at 15 months).
NFBC1966
NFBC1966 followed pregnancies with an expected delivery date
in the year 1966 in the Oulu and Lapland provinces of Finland
(53). A total of 5403 samples were available for analysis from
NFBC1966. In NFBC1966, ‘age at first tooth’ and ‘number of
teeth’ were gathered by public health professionals during the
children’s monthly visits to child welfare centres. ‘Age at first
tooth’ was recorded as the month of visit at which the first
tooth was observed (so that the first tooth could have erupted
at any time between the end of the previous month and the
recorded month, i.e. ‘interval censoring’). The number of teeth
was recorded at 12 months. All aspects of the study were
reviewed and approved by the Ethics Committee of the Univer-
sity of Oulu and by the respective local research committees.
Participants gave written informed consent to be included in
the study.
Genotyping
ALSPAC
In total, 9912 participants were genotyped using the Illumina
HumanHap550 quad genome-wide SNP genotyping platform
by 23andMe subcontracting the Wellcome Trust Sanger Insti-
tute, Cambridge, UK, and the Laboratory Corporation of
America, Burlington, NC, USA. Individuals were excluded
from analyses on the basis of excessive or minimal heterozygos-
ity, gender mismatch, individual missingness (.3%), cryptic re-
latedness as measured by identity by descent (genome-wide IBD
.10%) and sample duplication. Individuals were assessed for
population stratification using multi-dimensional scaling mod-
elling seeded with HapMap Phase II release 22 reference popu-
lations. Individuals of non-European ancestry were removed
from further analysis. SNPs with a final call rate of ,95%,
minor allele frequency (MAF) ,1% and evidence of departure
from Hardy–Weinberg equilibrium (HWE) (P , 5 × 1027)
were also excluded from analyses. After data cleaning, 5998
and 6609 individuals had complete phenotype and genotype
data for the analysis of ‘age at first tooth’ and ‘number of
teeth’, respectively. Individuals were imputed to HapMap
Phase II (Build 36, release 22) using the Markov Chain Haplo-
typing software (MACH v.1.0.16) (32). X chromosome imput-
ation was carried out on the non-pseudo autosomal region of
the X chromosome only, using CEU individuals from HapMap
Phase III (release 2). Only SNPs exceeding an rsq imputation
quality metric of 0.3 and an MAF of.1% were included in sub-
sequent analyses.
NFBC1966
The Illumina HumanCNV370-Duo DNA Analysis BeadChip
was used for genotyping NFBC1966. SNPs were excluded
from the analysis if the call rate in the final sample was
,95%, if there was a lack of HWE (P , 5 × 1024) or if the
MAF was ,1%; more details of genotyping and quality
control procedures can be found in Sabatti et al. (53). After
quality control, 328 077 SNPs were available for imputation. Im-
putation was carried out using IMPUTEv1 with CEU haplotypes
from HapMap Phase II (release 21) as the reference panel. X
chromosome imputation was carried out in the
non-pseudo-autosomal region of the X chromosome (54). Only
SNPs exceeding an ‘info’ metric of 0.3 and an MAF of .1%
were included in subsequent analyses. After data cleaning,
5120 and 4904 individuals had complete phenotype and geno-
type data for the analysis of ‘age at first tooth’ and ‘number of
teeth’, respectively.
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Statistical analysis
In order to account for censoring of the data, the association
between expected allelic dosage and ‘age at first tooth’ was ana-
lysed using parametric survival analysis, with the Gaussian dis-
tribution used to model event time. The ALSPAC data were
modelled as ‘right censored’, whereas the data in NFBC1966
were modelled as ‘interval censored’. The association between
expected allelic dosage and the number of teeth was analysed
using proportional odds logistic regression (ordinal regression).
Teeth are known to erupt in pairs; hence Poisson regression
(which assumes that the events of interest are independent)
was not appropriate. Analyses were adjusted for sex (ALSPAC
and NFBC1966), gestational age (ALSPAC and NFBC1966)
and age of completion (ALSPAC only, all NFBC1966 measure-
ments were recorded at 12 months). In addition, in NFBC1966,
the top 10 ancestry-derived principal components were tested for
association with the phenotypes and were included in the GWAS
of that phenotype if they associated at P , 0.05. This resulted in
the inclusion of the second principal component in the
NFBC1966 analysis of tooth eruption, and no principal compo-
nents in the analysis of ‘number of teeth’. Data were analysed
using the R software package 2.9.1.
Results from both studies were combined using a fixed effects
inverse variance meta-analysis, using the software package
METAL (55). This approach weights effect size estimates
according to the inverse of their standard errors. Variance
explained by each SNP was calculated as 12 var(res.full)/
var(res.null)∗100 of the model (proportional odds logistic re-
gression/survival regression) with age at measurement, sex
and gestational age (var, variance; res, residuals). To correct
for over-fitting each individuals, phenotype was estimated
from a model that did not include that individual (6).
In order to investigate the possibility of secondary signals at
loci that met the criteria for genome-wide significance (defined
as P , 5 × 1028), conditional regression analyses were per-
formed conditioning on the most strongly associated SNP in
each region. We then applied the Nyholt method for multiple
testing correction to derive a threshold for determining statistical
significance based on the number of SNPs tested and taking into
account LD across the region (10). These regions were defined
based on locations of nearby recombination hot spots. In
absence of these, we defined a region as +250 kb from the top
SNP.
We then investigated whether any of our genome-wide signifi-
cant loci exerted pleiotropic actions by looking at their associ-
ation with height, craniofacial shape and size and permanent
tooth eruption. In the case of height, we conducted linear regres-
sion of height measured at age 17 (in ALSPAC) and age 31 (in
NFBC) on genome-wide significant SNPs from Table 1. For cra-
niofacial shape and size, we looked up genome-wide significant
SNPs from the present study in the results from a previous
GWAS of the 54 variables characterizing different facial fea-
tures consisting of facial height, width, convexity and promin-
ence of landmark in respect to facial planes (11) (see
Supplementary Material, Fig. S4, for a list of distances exam-
ined). To account for multiple testing, empirical levels of signifi-
cance were determined using permutation analyses, where for
each SNP, genotype was permuted with respect to the 54 cranio-
facial variables. In this way, an adjusted P-value could be
calculated for each SNP, which took into account the fact that as-
sociation had been tested across the 54 correlated variables.
Analyses involving secondary tooth eruption were performed
using data from the Danish National Birth Cohort (7). The geno-
type data were derived from two on-going GWASs of preterm
birth (56) and obesity (57). The study combined all observations
between age 6 and 14 years (starting with the 6th and stopping
with the 14th birthday), the time period when eruption of per-
manent dentition usually occurs. For each visit to the dentist,
the total number of permanent teeth (excluding third molars)
was recorded, and regressed on age. The resulting residuals
were then standardized, and for each individual the mean re-
sidual across all available records was used as the phenotype.
Genotypes for the two GWASs were imputed separately using
MACH (54). The resulting imputed genotypes were analysed
separately and meta-analysed with METAL (55).
Pathway analyses of the ‘age at first tooth’ and ‘number of
teeth’ GWASs were performed using the ALIGATOR method
(13). The implementation of ALIGATOR described in Holmans
et al. (13) maps genes to gene ontology categories; however, the
method is equally applicable to other gene to pathway mappings
and we used ALIGATOR to test for the enrichment of significant
genes within biological pathways; significant genes are defined by
the method as those with one or more SNPs with an association
P-value less than a predefined threshold within the gene. We con-
sidered 2276 pathways curated by the Broad Institute (http
://www.broadinstitute.org/gsea/), as well as pathways from
‘Pathway Commons’ (http://www.pathwaycommons.org/pc/
home.do) and additional inflammatory pathways (58,59). All gen-
otyped and imputed SNPs with minor allele frequencies of.0.05
were included in the analyses. The method corrects for variable
gene size, and multiple testing of non-independent pathways
using permutation. All ALIGATOR analyses used 10 000 simu-
lated replicate gene lists and 2000 simulated replicate studies.
We compared results using P-value thresholds for association at
0.005, 0.001 and 0.0005 and 0.0001, and as suggested Holmans
et al. (13) report results fromthe analysis showing themost signifi-
cant enrichment of pathways.
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